David Durantel

Université Claude Bernard Lyon 1 — France

Medicine · Health Sciences

49h-index9.6kcitations233works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(145), Hepatitis C virus research(137), Liver Disease Diagnosis and Treatment(61), Hepatitis Viruses Studies and Epidemiology(27), interferon and immune responses(19)

Publications233 total

Corrigendum to “An alternative model for HEV infection in the HepaRG cell line” [J. Virol. Methods 340 (2026) 115307]
Journal of Virological Methods·2025Open Access
An alternative model for HEV infection in the HepaRG cell line
Journal of Virological Methods·2025Open Access
Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20–24, 2024, organized by the International Society for Antiviral Research
UNC Libraries·2025Open Access
Novel Dimeric Capsid Assembly Modulators as a Unique Class of Highly Potent Anti-HBV Agents
Journal of Medicinal Chemistry·2025
An optimized model for HEV infection in the HepaRG cell line
2025Open Access
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17–21, 2025
Antiviral Research·2025Open Access
TRIM proteins: A ‘swiss army knife’ of antiviral immunity
PLoS Pathogens·2025· 12 citedOpen Access
OS-074 Recombinant polyclonal antibody GIGA-2339 potently neutralizes hepatitis B and hepatitis D virus
Journal of Hepatology·2025· 2 cited
TOP-299 HDV infection induces cellular refractoriness to IFN-ɑ, but not IFN-λ treatment
Journal of Hepatology·2025
FRI-242 FXR agonists as broad-acting antivirals against HBV/HDV/HEV and other hepato(cyto)tropic viruses
Journal of Hepatology·2025
A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses
JHEP Reports·2025· 2 citedOpen Access
HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients’ clinical stage
Hepatology Communications·2025· 3 citedOpen Access
Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20–24, 2024, organized by the International Society for Antiviral Research
Antiviral Research·2024· 1 citedOpen Access
The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA
PLoS ONE·2024· 2 citedOpen Access
Characterization of HepaRG cell line in the context of HEV-3 infection
SPIRE - Sciences Po Institutional REpository·2024
THE DUAL-SPECIFICITY KINASE DYRK1A INTERACTS WITH THE HEPATITIS B VIRUS GENOME AND REGULATES THE PRODUCTION OF VIRAL RNA
2024Open Access
SAT-389 HBV and HBsAg strongly reshape the phenotype, function and metabolism of DCs according to patients’ clinical stage
Journal of Hepatology·2024
Deciphering the phospho-signature induced by hepatitis B virus in primary human hepatocytes
Frontiers in Microbiology·2024· 7 citedOpen Access
The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response
Oncotarget·2024· 5 citedOpen Access
Deciphering the phospho-signature induced by hepatitis B virus in primary human hepatocytes
2024Open Access
page 1 of 12Next →

Frequent Co-authors

Fabien Zoulim(35), Julie Lucifora(15), Raymond A. Dwek(7), Nicole Zitzmann(7), Barbara Testoni(7), François–Loïc Cosset(6), Maud Michelet(6), Michel Rivoire(6), Massimo Levrero(5), Sandra Carrouée‐Durantel(5), Nathalie Isorce(5), O. Hantz(4), Norica Branza‐Nichita(4), Judith Fresquet(4), Ourania Andrisani(4), Souphalone Luangsay(4), Suzanne Faure‐Dupuy(4), Malika Ait‐Goughoulte(4), Anna Salvetti(4), Raymond F. Schinazi(3)